Literature DB >> 22966898

Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary.

Damian Purcell1, Anthony Cunningham, Stuart Turville, Gilda Tachedjian, Alan Landay.   

Abstract

A group of over 200 international scientists came together on April 15 in Sydney, Australia just before the 2012 International Microbicides Conference as a part of a workshop to address the basic concepts and factors that modulate HIV infection at the mucosal surface. The meeting focused on defining the interaction between virus, prevailing host physiology, microbiota, and innate and adaptive immune responses and how they combine to impact the outcome at the moment of potential viral transmission. Speakers examined the biology of HIV entry during transmission, innate and natural antiviral mechanisms at the mucosa, microbicide efficacy, pharmacokinetic, and pharmacodynamics, animal models, and opportunities for combining HIV prevention strategies. Other viral infection models both in vivo and in vitro were considered for the insights they provided into HIV transmission events. The workshop raised important questions that we need to answer to further our basic understanding of host and viral factors influencing HIV transmission to inform the development of novel prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22966898      PMCID: PMC3484787          DOI: 10.1089/AID.2012.0276

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  38 in total

Review 1.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

2.  High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques.

Authors:  Sundaram A Vishwanathan; Patricia C Guenthner; Carol Y Lin; Charles Dobard; Sunita Sharma; Debra R Adams; Ron A Otten; Walid Heneine; R Michael Hendry; Janet M McNicholl; Ellen N Kersh
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-01       Impact factor: 3.731

Review 3.  Viruses and Langerhans cells.

Authors:  Anthony L Cunningham; Allison Abendroth; Cheryl Jones; Najla Nasr; Stuart Turville
Journal:  Immunol Cell Biol       Date:  2010 May-Jun       Impact factor: 5.126

Review 4.  Innate and acquired immunity in the human penile urethra.

Authors:  Jeffrey Pudney; Deborah Anderson
Journal:  J Reprod Immunol       Date:  2011-02-24       Impact factor: 4.054

5.  Finally, a macaque model for cell-associated SIV/HIV vaginal transmission.

Authors:  Deborah J Anderson
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

Review 6.  Role of semen in HIV-1 transmission: inhibitor or facilitator?

Authors:  Gustavo F Doncel; Theresa Joseph; Andrea R Thurman
Journal:  Am J Reprod Immunol       Date:  2010-11-19       Impact factor: 3.886

7.  One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates.

Authors:  Paul W Denton; Florence Othieno; Francisco Martinez-Torres; Wei Zou; John F Krisko; Elisa Fleming; Sima Zein; Daniel A Powell; Angela Wahl; Youn Tae Kwak; Brett D Welch; Michael S Kay; Deborah A Payne; Philippe Gallay; Ettore Appella; Jacob D Estes; Min Lu; J Victor Garcia
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

8.  Role of novel type I interferon epsilon in viral infection and mucosal immunity.

Authors:  Yang Xi; Stephanie L Day; Ronald J Jackson; Charani Ranasinghe
Journal:  Mucosal Immunol       Date:  2012-05-23       Impact factor: 7.313

9.  Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation.

Authors:  Martin P Cranage; Carol A Fraser; Alethea Cope; Paul F McKay; Michael S Seaman; Tom Cole; A Nasir Mahmoud; Joanna Hall; Elaine Giles; Gerald Voss; Mark Page; Neil Almond; Robin J Shattock
Journal:  Vaccine       Date:  2010-12-25       Impact factor: 3.641

10.  In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide.

Authors:  Deirdre E O'Hanlon; Thomas R Moench; Richard A Cone
Journal:  BMC Infect Dis       Date:  2011-07-19       Impact factor: 3.090

View more
  2 in total

Review 1.  Cell-associated transmission of HIV type 1 and other lentiviruses in small-animal models.

Authors:  Thomas R Moench
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

2.  Improving Adherence to Post-Cervical Biopsy Sexual Abstinence in Kenyan Female Sex Workers.

Authors:  Julie Lajoie; Genevieve Boily-Larouche; Kelsie Doering; Juliana Cheruiyot; Julius Oyugi; Kristina Broliden; Joshua Kimani; Keith R Fowke
Journal:  Am J Reprod Immunol       Date:  2016-05-24       Impact factor: 3.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.